These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2677935)

  • 1. Developmental pharmacology: ontogenic basis of drug disposition.
    Reed MD; Besunder JB
    Pediatr Clin North Am; 1989 Oct; 36(5):1053-74. PubMed ID: 2677935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric clinical pharmacology. A practical review.
    Udkow G
    Am J Dis Child; 1978 Oct; 132(10):1025-32. PubMed ID: 362892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretics in pediatrics : current knowledge and future prospects.
    van der Vorst MM; Kist JE; van der Heijden AJ; Burggraaf J
    Paediatr Drugs; 2006; 8(4):245-64. PubMed ID: 16898855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology and optimal therapeutics in developing countries: aspirations and hopes of the Pediatric Clinical Pharmacology Subcommittee.
    MacLeod SM
    J Clin Epidemiol; 1991; 44 Suppl 2():89S-93S. PubMed ID: 2045848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacology.
    Smits A; Annaert P; Allegaert K
    Int J Pharm; 2013 Aug; 452(1-2):8-13. PubMed ID: 22504091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basics and dynamics of neonatal and pediatric pharmacology.
    Seyberth HW; Kauffman RE
    Handb Exp Pharmacol; 2011; 205():3-49. PubMed ID: 21882104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Workshop on Perinatal and Pediatric Aspects of Clinical Pharmacology. Heidelberg, Federal Republic of Germany, 27-29 February, 1980.
    Eur J Clin Pharmacol; 1980 Jul; 18(1):1-127. PubMed ID: 7398739
    [No Abstract]   [Full Text] [Related]  

  • 8. Developmental Pharmacokinetics in Neonates: Maturational Changes and Beyond.
    Allegaert K; Mian P; van den Anker JN
    Curr Pharm Des; 2017; 23(38):5769-5778. PubMed ID: 28950819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of antifungal agents in pediatrics: children are not small adults.
    Ramos-Martín V; O'Connor O; Hope W
    Curr Opin Pharmacol; 2015 Oct; 24():128-34. PubMed ID: 26366938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
    Elmorsi Y; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
    Kinalski M; Sledziewski A; Kretowski A
    Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental assessment of prematurely born children exposed to antenatal corticosteroids.
    Arad I; Bromiker R
    Isr Med Assoc J; 2003 Sep; 5(9):659-61. PubMed ID: 14509158
    [No Abstract]   [Full Text] [Related]  

  • 14. Current clinical pharmacology issues in pregnancy and pediatrics.
    DeVane CL
    Pharmacotherapy; 2023 May; 43(5):358. PubMed ID: 37143437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of selected methods for intrauterine stimulation of fetal pulmonary maturation].
    Sledziewski A; Kinalski M; Kretowski A
    Przegl Lek; 2000; 57(3):171-7. PubMed ID: 10909290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can positron emission tomography facilitate paediatric drug development?
    Zimmer L
    Fundam Clin Pharmacol; 2008 Dec; 22(6):595-8. PubMed ID: 19049660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric pharmacology: who will test the drugs?
    Wilson JT
    J Pediatr; 1972 May; 80(5):855-7. PubMed ID: 5018400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.